Immutep Limited

NASDAQ:IMMP

Biotechnology

Healthcare
$0.37 +0.64%

+$0.00 today

Market cap
$55.01M
Beta
2.24
P/E (TTM)
-0.9
EPS (TTM)
-$0.06
52W Low $0.29High $3.53

Volume 3.10M

Average 13.46M

IMMP Total Current Assets

All assets expected to be converted to cash or used up within one year.

Immutep LimitedNASDAQ: IMMP

Total Current Assets · Q2 FY2026 · quarter ended Dec 2025

Total current assets falls 19.6% from a year ago

Total current assets stood at A$139.79M at the end of Q2 FY2026, down 19.6% from a year earlier. Over 3 fiscal years it compounded at +18.0% a year.

Context

  • Total current assets amounted to 95.0% of total assets at the end of Q2 FY2026, down 0.3 pp from a year earlier.
  • Total current assets increased in 2 of the last 3 fiscal years.

What to watch

Whether total current assets keeps falling in the next quarterly balance sheet after a -19.6% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterDec 2025
A$139.79M— QoQ
Last fiscal yearJun 2025
A$149.1M-22.1% YoY
Year agoDec 2024
A$173.76M-19.6% since
Total Current Assets past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-19.6%——
1 year-22.1%——
3-year CAGR+18.0%——
5-year CAGR——
10-year CAGR——

Total Current Assets history

AUD · from the balance sheet

Latest · FY2025
149.1M AUD
Year-over-year change
-22.1%
4-year CAGR
+21.5%

Total Current Assets vs competitors

How IMMP compares with its peers on the latest reported figures

  • Peers report in different currencies, so total current assets is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -19.6% is the 6th highest of 11, against a peer median of -18.6%.
  • Total current assets amounts to 95.0% of total assets for IMMP, versus a peer median of 86.3%.
IMMP Competitors
Total Current Assets for IMMP and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
VNDAVanda Pharmaceuticals Inc.Mar 2026$293.17M USD-28.1%-12.6%67.6%
CAPRCapricor Therapeutics, Inc.Mar 2026$283.09M USD+93.6%+96.0%86.8%
ALLOAllogene Therapeutics, Inc.Mar 2026$273.29M USD-6.3%-21.3%69.0%
TRDAEntrada Therapeutics, Inc.Mar 2026$266.87M USD-33.8%+13.4%79.5%
CADLCandel Therapeutics, Inc.Mar 2026$197.75M USD+112.3%+18.5%97.9%
IMMPImmutep LimitedDec 2025A$139.79M AUD-19.6%+18.0%95.0%
EDITEditas Medicine, Inc.Mar 2026$128.07M USD-43.0%-22.8%85.8%
CABACabaletta Bio, Inc.Mar 2026$122.32M USD-9.1%+8.5%82.6%
PRQRProQR Therapeutics N.V.Mar 2026€87.07M EUR-41.6%-13.5%87.8%
MREOMereo BioPharma Group plcMar 2026$40.03M USD-40.2%-15.7%98.6%
ACHVAchieve Life Sciences, Inc.Mar 2026$31.06M USD+24.2%+13.4%93.8%
Peer median (excluding IMMP) —-18.6%-2.0%86.3%

Competitors are the stored peer set for IMMP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

AUD
Metric
FY2021
Jun 2021
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
Cash & Equivalents60.13M80M123.42M161.79M67.41M
Short-term Investments00020.09M62.28M
Net Receivables6.12M8.37M7.97M7.56M7.46K
Inventory(5.66M)0000
Other Current Assets6.16M00010.87M
Total Current Assets68.42M90.81M134.97M191.35M149.1M
Property, Plant & Equipment (Net)309.7K308.08K468.51K679.72K569.48K
Goodwill109.96K109.96K109.96K109.96K109.96K
Intangible Assets12.74M10.44M9.38M8.13M7.09M
Long-term Investments00000
Tax Assets00000
Other Non-current Assets454.19K495.66K2.52M1.31M116.64K
Total Non-current Assets13.61M11.36M12.48M10.23M7.89M
Total Assets82.03M102.17M147.45M201.58M156.98M
Account Payables1.82M2.87M5.45M3.79M5.53M
Short-term Debt208.19K0001.1M
Tax Payables0(32.21M)000
Deferred Revenue00000
Other Current Liabilities2.75M3.02M354.84K428.71K446.95K
Total Current Liabilities5.34M6.41M9.77M10.49M12.76M
Long-term Debt2.53M1.45M835.45K960.76K0
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities811.88K117.25K164.43K211.02K274.31K
Total Non-current Liabilities3.42M1.68M1.21M1.57M589.23K
Total Liabilities8.76M8.09M10.98M12.06M13.35M
Common Stock313.42M367.41M446.27M542.11M535.07M
Retained Earnings(274.64M)(302.34M)(339.93M)(382.65M)(444.08M)
Accumulated OCI34.49M29M30.13M30.06M52.65M
Other Stockholders Equity00000
Minority Interest00000
Total Equity73.27M94.08M136.47M189.52M143.64M
Total Debt2.82M1.73M1.23M1.59M1.63M
Net Debt(57.31M)(78.26M)(122.19M)(160.2M)(65.78M)

Immutep Limited

NASDAQ:IMMP

Intrinsic Alpha fair value

Locked

Current Price

$0.37

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.